Does phosphodiesterase inhibition by naloxone augment the inotropic actions of beta-adrenergic stimulation?
The enhancement of myocardial contractility by naloxone in the presence of stimulation of adenylyl cyclase activity appears to be mediated by inhibition of PDE, specifically PDE III.
ERAP2 might be associated with CLNM in PTMC.